Premature ejaculation also called as rapid ejaculation, premature climax or early ejaculation. It is a disorder, which causes early ejaculation of semen during sexual intercourse. Premature ejaculation is a very common problem, and its exact cause is not known. However, causes include early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.
Ejaculation means discharging of semen from the body. Premature ejaculation (PE) also known as rapid ejaculation, premature climax or early ejaculation is a condition in which the ejaculation happens earlier than a man or his partner would like during a sexual intercourse. The main sign of PE is incapability to delay ejaculation for more than one minute after penetration. Mainly PE can be classified in two types, namely lifelong (primary) PE and acquired (secondary) PE.
To Get Download Sample Copy Of This Report:
https://www.coherentmarketinsights.com/insight/request-sample/1956
Lifelong (primary) PE is a condition, which affects a male lifelong, nearly from the beginning of his first sexual encounter. Acquired (secondary) PE is a condition in which a male who has a normal sex life starts suffering from PE. The actual cause of PE is not known, however, it can caused due to some psychological and biological factors such as early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.
Key players in the market are focusing on launching new products, which in turn is expected to aid in growth of the market. For instance, in 2012, Absorption Pharmaceuticals, LLC launched its Promescent, an over-the-counter lidocaine-based spray, indicated for premature ejaculation. Furthermore, in 2013, Absorption Pharmaceuticals, LLC received patent for its Promescent, for premature ejaculation (PE) from the U.S. Patent and Trademark Office. The launches of novel drugs, which are indicated for the treatment of premature ejaculation is expected to fuel growth of the global premature ejaculation treatment market in the near future.
The global premature ejaculation treatment market size was valued at US$ 1.5 Bn in 2017, and is expected to witness a CAGR of 8.7% over the forecast period (2018 – 2026).
To Get Download PDF Copy Of This Report:
https://www.coherentmarketinsights.com/insight/request-pdf/1956
Furthermore, key players are involved in raising funds for the development of drugs and are focused on expanding its sales network, in order to increase their sales. For instance, in 2013, Absorption Pharmaceuticals LLC, a manufacturer of Promescent spray indicated for treatment of premature ejaculation, expanded its international sales team. In 2014, Vyrix Pharmaceuticals, Inc., a subsidiary of Aytu BioScience, raised around US$ 28.75 million. The company financed development of tramadol hydrochloride (Zertane), indicated for the treatment of premature ejaculation from these funds.
Increasing prevalence of premature ejaculation is expected to increase demand for premature ejaculation drugs. For instance, according to the data published by European Association of Urology in 2017, the prevalence rate of premature ejaculation in the U.S. was estimated to be 30% (18-29 years), 32% (30-39 years), 28% (40-49 years), and 55% (50-59 years). According to the same source, the prevalence rate of four sub-types of erectile dysfunction was were 2.3% (lifelong PE), 3.9% (acquired PE), 8.5% (natural variable PE), and 5.1% (premature-like ejaculatory dysfunction). Such high prevalence of premature ejaculation is expected to lead to high demand for its treatment drugs and drive premature ejaculation treatment market growth.
To Get More Information This Report:
https://www.coherentmarketinsights.com/market-insight/premature-ejaculation-treatment-market-1956

About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.
Contact Us:
Name: Mr. Raj Shah
Email: [email protected]
Phone: US +12067016702
Country: United States
Visit our Blog: https://hospitalhealthcareblog.wordpress.com/